Over the past few weeks, we have observed the discourse that has emerged due to ABCT’s Apology for Behavior Therapy’s Contribution to the Development and Practice of Sexual Orientation and Gender Identity and Expression Change Efforts: History and Next Steps. SSCP and ABCT are ‘sibling organizations’ that are highly collaborative and share a large number of members. We support ABCT’s apology statement and the Silverstein Award. We also want to acknowledge and support the Sexual and Gender Minority Special Interest Group, whose hard work, courage, and assertiveness pushed the cognitive and behavioral therapy fields to center LGBTQ+ voices in decision-making. We recognize the fear, emotional pain, bravery, and strong advocacy it took to speak out effectively and create change.
On behalf of SSCP, we apologize for the complicit role SSCP had in the support or promotion of conversion therapies. We commit to assisting in the wide dissemination of the harms and lack of efficacy of conversion therapies, and the stopping of its use. The burden of stopping the practice of harmful therapies is shared by all organizations committed to clinical psychological science. We support a transparent and evidence-based approach in order to reduce the harmful impact of publications on conversion therapies. We acknowledge the pain that revelations regarding publications relating to sexual orientation and gender identity and expression change efforts have caused many members of the LGBTQ+ community both within our field and outside of it. We support the desire to stop the harm of such articles and disseminate the ineffectiveness and harm of conversion therapies. We call for LGBTQ+ voices within our community to be centered in discussions of a course forward in regards to these articles that will mitigate harm and promote healing.
On June 16, 2022 the SSCP Board met and focused on the actions SSCP could take to center the Sexual and Gender Minority voices and stop the practice of harmful therapies in our field. We will work on:
The SSCP Board commits to routinely discussing ways we can continue to advance clinical science, best practices, dissemination of clinical science, and mental health of Sexual and Gender Minorities.